UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010710
Receipt number R000012517
Scientific Title Effective treatment of rebamipide on xerostomia in Sjogrens syndrome patients:a pilot study -a double-blind placebo-controlled trial-
Date of disclosure of the study information 2013/05/15
Last modified on 2016/12/03 21:38:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effective treatment of rebamipide on xerostomia in Sjogrens syndrome patients:a pilot study -a double-blind placebo-controlled trial-

Acronym

Effective treatment of rebamipide on xerostomia

Scientific Title

Effective treatment of rebamipide on xerostomia in Sjogrens syndrome patients:a pilot study -a double-blind placebo-controlled trial-

Scientific Title:Acronym

Effective treatment of rebamipide on xerostomia

Region

Japan


Condition

Condition

Xerostomia in Sjogrens syndrome

Classification by specialty

Oral surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We precede it if we perform randomized controlled trial to inspect preeminence of rebamipide, size of effect size for control medicine, size of a change between subjects.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Amount of increase in the unstimulated whole saliva secretion after administration 8W

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Rebamipide was administered orally at 100 mg each time three times a day after meals for 8 weeks.

Interventions/Control_2

Placebo was administered orally three times a day after meals for 8 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients was given Cevimeline hydrochloride hydrate or oral pilocarpine more than one year. However,the effect was insufficient.
Patients who could come to the outpatient clinic for at least 12 weeks.
Patients with a salivary flow rate of not more than 10 mL for 10 min in the chewing gum test and having subjective symptoms of xerostomia.
The person who gets mutual understanding.
Patients with white cell and platelet count judged to be normal.

Key exclusion criteria

Patients with a history of treatment or currently on treatment for facial or
trigeminal neuropathy.
Patients with a history of treatment or currently on treatment salivary gland disorders other than SS within 6 months before start of administration.
Patients with diabetes.
Patients with hypersensitivity to rebamipide.
Patients now taking or who took within one month previously rebamipide.
Patients taking other drug for the treatment of gastritis and gastric ulcer.
Patients who have or might have upper digestive tract, hepatic or biliary disease.
Patients with severe hepatic dysfunction or renal dysfunction.
Women who are pregnant or who might be pregnant or lactating mothers.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Iwabuchi

Organization

Tochigi medical center

Division name

Department of Dentistry and Oral Surgery

Zip code


Address

1-10-37 Nakatomatsuri Utsunomiya-city Tochigi

TEL

81-28-622-5241

Email

hiwabuch@tochi.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Iwabuchi

Organization

Tochigi medical center

Division name

Department of Dentistry and Oral Surgery

Zip code


Address

1-10-37 Nakatomatsuri Utsunomiya-city Tochigi

TEL

81-28-622-5241

Homepage URL


Email

hiwabuch@tochi.hosp.go.jp


Sponsor or person

Institute

Tochigi medical center

Institute

Department

Personal name



Funding Source

Organization

Clinical research division of tochigi medical center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 02 Month 18 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 15 Day

Last follow-up date

2014 Year 04 Month 30 Day

Date of closure to data entry

2014 Year 05 Month 31 Day

Date trial data considered complete

2014 Year 06 Month 30 Day

Date analysis concluded

2014 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 14 Day

Last modified on

2016 Year 12 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012517


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name